Four Outbreaks, One Weakness: Surveillance That Reaches Too Late
Cyclospora, H5N1, Ebola and mpox produced very different problems this week, and exposed the same gap between detection capability and detection reach.
Four separate infectious disease stories this week, involving four unrelated pathogens. Taken individually they are routine public health news. Taken together they describe a consistent structural weakness.
What happened
- Cyclospora: 1,645 confirmed domestic cases since 1 May, with more than 5,100 awaiting analysis — against 249 by this point last year. The FDA is running four separate investigations.
- H5N1: 25% of cats within two kilometres of an active dairy outbreak in Tulare County carried antibodies, against 4.1% of all cats sampled.
- Ebola: the DRC confirmed a case in North Kivu, two months after the outbreak was declared over, in rebel-held territory.
- Mpox: the FDA authorised emergency use of a diagnostic device.
The shared failure mode
In each case the technical capability exists. Cyclospora can be identified in a laboratory. H5N1 antibody testing works. Ebola diagnostics and vaccines are mature. Mpox tests are available.
The gap is in reach — whether the capability arrives where the infections are, in time:
- Cyclospora requires a specific test that is not in routine panels, so cases are found only where someone thought to look.
- H5N1 exposure in cats was discovered by a study, not by surveillance, because cats are not part of agricultural monitoring.
- The North Kivu case sits in territory the health ministry cannot enter.
- Mpox response required an emergency authorisation to make testing available at scale.
What good looks like
The same week produced a counter-example. Uganda met all three WHO 7-1-7 benchmarks in a cross-border Bundibugyo virus outbreak — detection in six days, same-day notification, early response completed in two.
Uganda's advantage is not superior technology. It is institutional depth built through repeated outbreaks, and a system positioned close enough to the population to notice quickly.
The conclusion
Detection speed is the variable that most reliably determines outbreak size, because growth is exponential and every day of delay compounds. Investment in surveillance reach — routine testing panels, animal monitoring, laboratory access in remote areas — is cheap relative to what late detection costs.
It is also invisible when it works, which is why it is consistently the first thing cut.